Does This Drug Maker For Hepatitis C Have More Upside?

Business Section: Investing Ideas

Companies mentioned in this article are:

 

1. Gilead Sciences Inc. (GILD, Earnings, Analysts, Financials): Engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. Market cap at $56.56B, most recent closing price at $74.65.

 

2. Vertex Pharmaceuticals Incorporated (VRTX, Earnings, Analysts, Financials): Engages in the discovery, development, and commercialization of small molecule drugs for the treatment of serious diseases worldwide. Market cap at $8.67B, most recent closing price at $39.98.

 

3. Merck & Co. Inc. (MRK, Earnings, Analysts, Financials): Provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. Market cap at $133.4B, most recent closing price at $43.88.

 

4. Bristol-Myers Squibb Company (BMY, Earnings, Analysts, Financials): Develops, and delivers innovative medicines that help patients prevail over serious diseases. Market cap at $53.83B, most recent closing price at $32.61.

 

 

Related Articles in this Sector:

• A Look at Amarin’s (AMRN) Sell-off and These 4 Companies
• Selloff with Arena (ARNA): 5 Reasons to Stay Positive

 

Written by Chris Lau. 

To interact and discuss these picks or picks of your own with users, attach your watch list or portfolio in a message to your friends on Kapitall. To connect with users on the leaderboard: from your tool bar, select Get Connected -> Top Kaptallists. Members on Kapitall earn free points, and even more points with every Kapitall Generation trade. These points may be redeemed at the Kapitall store.

 

Analyze These Ideas: Getting Started

null

« First ‹ Previous 1 2